AccuGene strives to become the leader in genomic analysis and molecular diagnostics research.
Researchers at AccuGene are conducting research in various fields in the medical environment such as
new technology development, product safety analysis, product development, etc.

R&D History

2021
2020

Jul

Publication featured in the Metabolites
(Title : Gut Microbiome and Metabolome Profiles Associated with High-Fat Diet in Mice)

Jun

Publication featured in the Metabolites
(Title : Identification of salivary microorganisms and metabolites associated with halitosis)

Feb

Registered patent for the conversion method of genetic information common data models

Dec

Selected as a company with excellence in the Big3 Project (Excellent evaluation items: Sales Growth and Job Creation)

Nov

Publication featured in the Molecules journal(Title : Effect of Fungi on Metabolite Changes in Kimchi During Fermentation)

Oct

AccuViral Collection Kit FDA EUA Registration

Aug

Publication featured in the LWT-Food Science and Technology(Title : Factors affecting vinegar metabolites during two-stage fermentation through metabolomics study)

Jul

The Korea Institute for the Advancement of Technology(KIAT) selects AccuGene as a company that supports the innovative growth of small and medium venture companies for “Gut Microbiome Analysis Service” in the BIG3 Sectors
Publication featured in the Journal of Microbiology(Title : Intervention with kimchi microbial community ameliorates obesity by regulating gut microbiota, 1 co-lead author, 1 co-author)

May

SMTECH selects AccuGene as a promising company in the market expansion project for the small and mid-sized venture companies
(Development of NGS-based medical device for the diagnosis of hereditary colorectal cancer)

Apr

AccuViral RNA Preparation Kit Development

Mar

AccuViral Collection Kit Development